VeriMomhydrolyzed keratin pg-propyl methylsilanediol hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive toxicity for this ingredient or its parent components; no peer‑reviewed reports of developmental/reproductive toxicity located in the queried sources (PubMed, CIR, SCCS, ECHA, CosIng, PubChem, EWG). Keratin hydrolysates are large peptide fragments and the silanol-containing modifier lacks harmonised reproductive hazard (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, CosIng, PubChem, EWG).
Pregnancy-safe products containing hydrolyzed keratin pg-propyl methylsilanediol
Related ingredients
Frequently asked questions
- hydrolyzed keratin pg-propyl methylsilanediol hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive toxicity for this ingredient or its parent components; no peer‑reviewed reports of developmental/reproductive toxicity located in the queried sources (PubMed, CIR, SCCS, ECHA, CosIng, PubChem, EWG). Keratin hydrolysates are large peptide fragments and the silanol-containing modifier lacks harmonised reproductive hazard (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, CosIng, PubChem, EWG).
- hydrolyzed keratin pg-propyl methylsilanediol emzirirken güvenli mi?
- No evidence from the prioritized sources of reproductive or lactation-specific toxicity, and no mechanism suggesting transfer into breastmilk identified in the available literature/databases. CIR/SCCS/ECHA do not list reproductive/lactation concerns for keratin hydrolysates or simple silanol propyl derivatives.
- hydrolyzed keratin pg-propyl methylsilanediol bebek cildi için güvenli mi?
- Hazard and mechanism: no evidence of reproductive or developmental toxicity specific to infants in the searched sources. Exposure: increased exposure score (+1) relative to adults because infant skin has higher surface‑area‑to‑weight and an immature barrier; although the ingredient likely has limited systemic bioavailability (large peptide fraction and polar silanol moiety), measurable percutaneous absorption cannot be excluded for small modifier moieties so a conservative exposure increase for 0–3 yr is applied. Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, CosIng, PubChem, EWG.
- VeriMom hydrolyzed keratin pg-propyl methylsilanediol nasıl puanlıyor?
- VeriMom hydrolyzed keratin pg-propyl methylsilanediol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hydrolyzed keratin pg-propyl methylsilanediol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.